期刊文献+

脉冲射频联合得保松治疗带状疱疹后神经痛的疗效观察 被引量:1

Efficacy of Pulsed RF modulation combined with Compound Betamethasone Injection to treat post herpetic neuralgia
下载PDF
导出
摘要 目的:观察脉冲射频调节联合得保松治疗带状疱疹后神经痛的疗效。方法:选择应用脉冲射频调节治疗带状疱疹后神经痛病人38例,脉冲射频调节联合得保松治疗组(A组)21例,单纯得保松治疗组(B组)17例。观察与记录患者治疗前、治疗后1周及治疗后3个月VAS评分,评定治疗效果优良率。结果:A组较B组VAS评分低(P<0.01),A组较B组优良率高(P<0.01),脉冲射频调节联合得保松治疗PHN,镇痛效果确切,有助于缓解患者症状、改善生活质量。结论:脉冲射频调节联合得保松治疗带状疱疹后神经痛效果安全有效。 Objective:To observe Pulsed RF modulation combined with Compound Betamethasone Injection to treat post herpetic neuralgia. Methods:38 patients with post herpetic neuralgia treated by Pulsed RF modulation combined with Betamethasone Injection, treatment group (A) regulating combined with 21 cases, simply Compound Betamethasone Injection treatment group (B) 17 cases Observe and record patients before treatment, 1 week after treatment and3 months after treatment VAS score to assess the treatment effect excellent rate. Results:A group of two sets of VAS scores (P 〈0.01), a group of two groups of good rate (P〈O.01). Pulsed RF modulation combined with Com- pound Betamethasone Injection to treat PHN proves accurate in analgesic effect, helpful to relieve symptoms and im- prove quality of life. Conclusion:Pulsed RF modulation combined with Compound Betamethasone Injection to treat post herpetic neuralgia is safe and effective.
出处 《安徽卫生职业技术学院学报》 2013年第4期43-44,共2页 Journal of Anhui Health Vocational & Technical College
关键词 脉冲射频调节 得保松 带状疱疹后神经痛 Pulsed RF modulation Compound Betamethasone Injection Post herpetic neuralgia
  • 相关文献

参考文献4

  • 1Jonhson RW. Zoster-associated pain:what is known,who is at risk and how can it be managed?her- pes,2007,14(Suppl 2):30-34.
  • 2Keskinbora K,Pekel AF,Aydinli I,Gabapentin and an poioid combination versus opioid alone for the management of neuropathie pain.J pain Symptom Manage,2007,34:182-186.
  • 3Nicholson B. Gabapentin use in neuropathic pain sybdromes.Acta Neurl Stand,2000,101:359-370.
  • 4Stein AN,Britt H,Harrison C,et al.herpes zoster burden of illness and health care resource utilization in the Sustralian population aged 50 years and oider. Vaccine,2009,27:520-527.

同被引文献20

引证文献1

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部